Scribe Therapeutics
PrivateLast Round
Convertible Debt
May 16, 2023
Total Funding Raised
$195M
Company Overview
Scribe Therapeutics is a biotechnology company that develops engineered CRISPR technologies aimed at treating genetic diseases through innovative biological preparations for various medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scribe Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Scribe Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 16, 2023 | ||||
| Series B | Mar 31, 2021 | ||||
| Series A | Oct 6, 2020 |
Scribe Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B, Series A |
| RA Capital Management | Series B |
| Perceptive Advisors | Series B |
| Avoro Ventures | Series B |
| Avoro Capital | Series B |
| OrbiMed | Series B |
| T. Rowe Price | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Will attend EAS Congress 2026 to highlight CRISPR platform advances.
- Apr 30, 2026
Will attend ASGCT 2026 to highlight CRISPR platform advances.
Scribe Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scribe Therapeutics's valuation, stock price, and market status.
